Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity
Abhishek S. Kashyap, Tamara Thelemann, Richard Klar, Sandra M. Kallert, Julia Festag, Melanie Buchi, Lisa Hinterwimmer, Monika Schell, Sven Michel, Frank Jaschinski, Alfred Zippelius
Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 67; DOI: 10.1186/s40425-019-0545-9